spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
xofluza
roche registration gmbh - baloxavir marboxil - gripa, ljudska - antivirusni lijekovi za sustavnu uporabu - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.
mmrvaxpro 1000 tcid50/1 doza+ 12500 tcid50/1 doza+ 1000 tcid50/1 doza prašak i rastvarač za rastvor za injekciju u napunjenoj š
merck sharp & dohme bh d.o.o. - kombinovana пропорциональному protiv morbila, parotitisa sam rubeole, ziva, atenuisana - prašak i rastvarač za rastvor za injekciju u napunjenoj šprici - 1000 tcid50/1 doza+ 12500 tcid50/1 doza+ 1000 tcid50/1 doza - 1 doza (0,5 ml) suspenzije za injekciju sadrži: ne manje od 1000 tcid50 živi atenuirani virus morbila, soj enders edmonston, ne manje od 12 500 tcid 50 živi atenuisani virus parotitisa (jeryl lynn soj), ne manje od 1000 tcid 50 živi atenuisani virus rubele (wistar ra 27/3 soj)
mmrvaxpro 1000 tcid50/1 doza+ 12500 tcid50/1 doza+ 1000 tcid50/1 doza prašak i rastvarač za rastvor za injekciju u napunjenoj š
merck sharp & dohme bh d.o.o. - kombinovana пропорциональному protiv morbila, parotitisa sam rubeole, ziva, atenuisana - prašak i rastvarač za rastvor za injekciju u napunjenoj šprici - 1000 tcid50/1 doza+ 12500 tcid50/1 doza+ 1000 tcid50/1 doza - 1 doza (0,5 ml) suspenzije za injekciju sadrži: ne manje od 1000 tcid 50 živi atenuirani virus morbila, soj enders edmonston, ne manje od 12500 tcid 50 živi atenuisani virus parotitisa (jeryl lynn soj), ne manje od 1000 tcid 50 živi atenuisani virus rubele (wistar ra 27/3 soj)
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - imuni serumi i homologna, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.
roctavian
biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).
gardasil 20 µg/0.5 ml+ 40 µg/0.5 ml+ 40 µg/0.5 ml+ 20 µg/0.5 ml suspenzija za injekciju
merck sharp & dohme bh d.o.o. - papilomavirus (humanitarne tipovi 6, 11, 16, 18) - suspenzija za injekciju - 20 µg/0.5 ml+ 40 µg/0.5 ml+ 40 µg/0.5 ml+ 20 µg/0.5 ml - 0,5 ml (1 doza) suspenzije za injekciju sadrži: 20 mcg humani papilomavirus tip 6 l1 protein 40 mcg humani papilomavirus tip 11 l1 protein 40 mcg humani papilomavirus tip 16 l1 protein 20 mcg humani papilomavirus tip 18 l1 protein
gardasil 20 µg/0.5 ml+ 40 µg/0.5 ml+ 40 µg/0.5 ml+ 20 µg/0.5 ml suspenzija za injekciju
merck sharp & dohme bh d.o.o. - papilomavirus (humanitarne tipovi 6, 11, 16, 18) - suspenzija za injekciju - 20 µg/0.5 ml+ 40 µg/0.5 ml+ 40 µg/0.5 ml+ 20 µg/0.5 ml - 0,5 ml (1 doza) suspenzije za injekciju sadrži: 20 mcg humani papilomavirus tip 6 l1 protein 40 mcg humani papilomavirus tip 11 l1 protein 40 mcg humani papilomavirus tip 16 l1 protein 20 mcg humani papilomavirus tip 18 l1 protein
gardasil 20 µg/0.5 ml+ 40 µg/0.5 ml+ 40 µg/0.5 ml+ 20 µg/0.5 ml suspenzija za injekciju u napunjenoj šprici
merck sharp & dohme bh d.o.o. - papilomavirus (humanitarne tipovi 6, 11, 16, 18) - suspenzija za injekciju u napunjenoj šprici - 20 µg/0.5 ml+ 40 µg/0.5 ml+ 40 µg/0.5 ml+ 20 µg/0.5 ml - 0,5 ml (1 doza) suspenzije za injekciju u napunjenoj šprici sadrži: 20 mcg humani papilomavirus tip 6 l1 protein 40 mcg humani papilomavirus tip 11 l1 protein 40 mcg humani papilomavirus tip 16 l1 protein 20 mcg humani papilomavirus tip 18 l1 protein